Standout Papers
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease (2020)
- The Pregnancy Risk Assessment Monitoring System (PRAMS): Overview of Design and Methodology (2018)
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease (2021)
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease (2020)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021)
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease (2020)
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020)
Citation Impact
1 by Nobel laureates 17 from Science/Nature 87 standout
Citing Papers
Single-cell multiregion dissection of Alzheimer’s disease
2024 StandoutNature
Emerging diagnostics and therapeutics for Alzheimer disease
2023 Standout
Works of Ruben Smith being referenced
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
2021 Standout
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
2020 Standout
Author Peers
| Author | Physiology | PMh | RNMI | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Ruben Smith | 3908 | 3015 | 744 | 1366 | 145 | 6.9k | |
| W. David Klemperer | 2 | 21 | 320 | ||||
| J Cophignon | 28 | 7 | 30 | 34 | 86 | 1.4k | |
| William P. Leser | 2 | 24 | 353 | ||||
| S. Dighe | 139 | 7 | 7 | 383 | |||
| C. Sivapathasekaran | 1 | 1 | 193 | 13 | 458 |
All Works
Login with ORCID to disown or claim papers
Loading papers...